Topic Intelligence: nordisk

Last updated: 2026-04-14 17:23:47 ET

Overall Topic Sentiment (Range Avg): Strong Bullish 5,592.0

Mentions (24h)

vs prior 24h: +100.0%

Mentions (Range)

8 day range (Apr 7 - Apr 14)

Sentiment (Avg / Median)

55.9 / 89.3

Based on 5 articles in range

Sentiment Mix (Range)

60% 40% 0%

Coverage Z-Score

-0.15

24h mentions vs 90d baseline

Coverage & Sentiment Over Time

Share of Voice % Sentiment

Top Sources

Sentiment Mix

60% Bullish

60% Bullish 40% Neutral 0% Bearish

Related: novo wegovy biggest moves premarket jpmorgan chase united airlines posting partners openai drug discovery hopes mount partnership eli lilly share

Latest Articles on "nordisk" (Range)

CNBC Finance • 6h ago

Stocks making the biggest moves premarket: Novo Nordisk, JPMorgan Chase, United Airlines & more

These are the stocks posting the largest moves premarket.

Strong Bullish 100.0

CNBC Top Stories • 11h ago

Novo Nordisk partners with OpenAI as AI drug discovery hopes mount

The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.

Strong Bullish 89.3

CNBC Top Stories • 4d ago

Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India

Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic...

Strong Bullish 90.3

Market Watch • 6d ago

A high dose of Wegovy will cost $50 less than Zepbound

Novo Nordisk launched the high dose version of its GLP-1 injection at a price that’s $50 lower than the one for Eli Lilly’s competing drug.

Neutral 0.0

CNBC Business • 7d ago

Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment

CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug.